Moderated by:

Mara Antonoff, MD Anderson Cancer Center
Stephen Yang, Johns Hopkins Medical Institutions

High-Risk Stage I NSCLC: How Is It Defined and What Do We Do with It?

Prasad Adusumilli, Memorial Sloan Kettering Cancer Center

Technical Aspects of Lung Cancer Resections

Walter Weder, Thoraxchirurgie Bethanien

Defining and Targeting the Tumor Immune Microenvironment in NSCLC

Jonathan Spicer, McGill University Health Center

Panel Discussion with Q&A

All faculty

Recorded on December 17, 2025